Conclusion
The resuscitation of patients with trauma and hemorrhagic shock has improved over recent years but there is still a need to control bleeding that cannot be corrected surgically, particularly coagulopathic bleeding, in order to reduce the morbidity and mortality associated with major trauma.
Although blood component therapy remains the mainstay of management for coagulopathic bleeding, and RBC transfusion can be life-saving, many patients remain at risk of exsanguination, and there are well-documented post-injury problems associated with high rates of RBC transfusion in trauma. Hemostatic agents may offer effective adjunctive control in cases of coagulopathic bleeding, helping to reduce the reliance on transfusion and potentially decreasing the morbidity and mortality burden.
Blood transfusion therapy is unlikely to be replaced completely, but the role of new agents capable of improving bleeding control in emergency settings clearly warrants close consideration and further study.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
World Health Organization (2003) World Health Report 2003: Shaping the Future. World Health Organization, Geneva
Holcomb JB (2004) Methods for improved hemorrhage control. Crit Care 8(suppl 2):S57–S60
Hoyt DB (2004) A clinical review of bleeding dilemmas in trauma. Semin Hematol 41(suppl 1):40–43
Sauaia A, Moore FA, Moore EE, et al (1995) Epidemiology of trauma deaths: a reassessment. J Trauma 38:185–193
Carrico CJ, Holcomb JB, Chaudry IH, PULSE Trauma Work Group (2002) Post resuscitative and initial utility of life saving efforts. Scientific priorities and strategic planning for resuscitation research and life saving therapy following traumatic injury: report of the PULSE Trauma Work Group. Acad Emerg Med 9:621–626
Lynn M, Jeroukhimov I, Klein Y, Martinowitz U (2002) Updates in the management of severe coagulopathy in trauma patients. Intensive Care Med 28(suppl 2):S241–S247
MacLeod JBA, McKenney MG, Cohn SM, Murtha M (2003) Early coagulopathy predicts mortality in trauma. J Trauma 55:39–44
Spahn DR, Rossaint R (2005) Coagulopathy and blood component transfusion in trauma. Br J Anaesth 95:130–139
Bombeli T, Spahn DR (2004) Updates on perioperative coagulation: physiology and management of thromboembolism and haemorrhage. Br J Anaesth 93:275–287
Hoffman M (2003) A cell-based model of coagulation and the role of factor VIIa. Blood Rev 17(suppl 1):S1–S5
Moore EE (1996) Thomas G. Orr Memorial Lecture. Staged laparotomy for the hypothermia, acidosis, and coagulopathy syndrome. Am J Surg 172:405–410
Cosgriff N, Moore EE, Sauia A, Kenny-Moynihan M, Burch JM, Galloway B (1997) Predicting life-threatening coagulopathy in the massively transfused trauma patient. Hypothermia and acidosis revisited. J Trauma 42:857–861
Reiss RF (2000) Hemostatic defects in massive transfusion: rapid diagnosis and management. Am J Crit Care 9:158–165
Hardaway RM (1995) Trauma, sepsis, and disseminated intravascular coagulation. J Intensive Care Med 10:145–152
Ferrara A, MacArthur JD, Wright HK, Modlin IM, McMillen MA (1990) Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg 160:515–518
MacLeod J, Lynn M, McKenney MG, Jeroukhimov I, Cohn SM (2004) Predictors of mortality in trauma patients. Am Surg 70:805–810
Faringer PD, Mullins RJ, Johnson RL, Trunkey DD (1993) Blood component supplementation during massive transfusion of AS-1 red cells in trauma patients. J Trauma 34:481–485
Wolberg AS, Meng ZG, Monroe DM III, Hoffman M (2004) A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 56:1221–1228
Meng ZH, Wolberg AS, Monroe DM III, Hoffmann M (2003) The effects of temperature and pH on the activity of factor VIIa in hypothermic and acidotic patients. J Trauma 55:886–891
Council of Europe Publishing 2004. Guide to the Preparation, Use and Quality Assurance of Blood Components. Council of Europe Publishing, Strasburg
Stehling LC, Doherty DC, Faust RJ, et al (1996) Practice guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component therapy. Anesthesiology 84:732–747
Martinowitz U, Michaelson M; The Israeli Multidisciplinary rFVIIa Task Force (2005) Guidelines for the use of recombinant activated factor VIIa in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force. J Thromb Haemost 3:640–648
Dzik WH (2004) Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep 3:324–330
Armand R, Hess JR (2003) Treating coagulopathy in trauma patients. Transfus Med Rev 17:223–231
Hardy JF, Samama M (2003) Massive transfusion and coagulopathy. TATM 4:199–210
Shafi S, Kauder DR (2004) Fluid resuscitation and blood replacement in patients with polytrauma. Clin Orthop Relat Res 422:37–42
Claridge JA, Sawyer RG, Schulman AM, McLemore EC, Young JS (2002) Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg 68:566–572
Edna TH, Bjerkeset T (1992) Association between blood transfusion and infection in injured patients. J Trauma 33:659–661
Moore FA, Moore EE, Sauaia A (1997) Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg 132:620–624
Como JJ, Dutton RP, Scalea TM, Edelman BB, Hess JR (2004) Blood transfusion rates in the care of acute trauma. Transfusion 44:809–813
Malone DL, Dunne J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM (2003) Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 54:898–905
Zallen G, Offner PJ, Moore EE, et al (1999) Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg 178:570–572
Vaslef SN, Knudsen NW, Neligan PJ, Sebastian MW (2002) Massive transfusion exceeding 50 units of blood products in trauma patients. J Trauma 53:291–295
Blajchman MA (2002) Immunomodulation and blood transfusion. Am J Ther 9:389–395
Schulman CI, Cohn SM (2004) Transfusion in surgery and trauma. Crit Care Clin 20:281–297
Leal-Noval SR, Jara-Lopez I, Garcia-Garmendia JL, et al (2003) Influence of erythrocyte concentration storage time on postsurgical morbidity in cardiac patients. Anesthesiology 98:815–822
Herbert PC, Wells G, Blajchman MA, et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340:409–417
McIntyre L, Hebert PC, Wells G, et al (2004) Is a restrictive transfusion strategy safe for resuscitated and critically ill trauma patients? J Trauma 57:563–568
Hiippala S (1998) Replacement of massive blood loss. Vox Sang 74(suppl 2):399–407
Stainsby D, MacLennan S, Hamilton PJ (2000) Management of massive blood loss: a template guideline. Br J Anaesth 85:487–491
Chowdhury P, Saaman AG, Paulus U, Findlay GP, Collins PW (2004) Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 125:69–73
Grosso SM, Keenan JO (2000) Whole blood transfusion for exsanguinating coagulopathy in a US filed surgical hospital in postwar Kosovo. J Trauma 49:145–148
Moore FA, McKinley BA, Moore EE (2004) The next generation in shock resuscitation. Lancet 363:1988–1996
Jurlander B, Thim L, Klausen NK, et al (2001) Recombinant activated factor VII (rFVIIa): characterization, manufacturing, and clinical development. Semin Thromb Hemost 27:373–383
Hoffman M, Monroe DM, Roberts HR (1998) Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis 9:S61–S65
Monroe DM, Hoffman M, Oliver JA, Roberts HR (1998) A possible mechanism of action of activated factor VII independent of tissue factor. Blood Coagul Fibrinolysis 9:S15–S20
Dutton RP, McCunn M, Hyder M, et al (2004) Factor VIIa for correction of traumatic coagulopathy. J Trauma 57:709–719
Grounds M (2003) Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review. Blood Rev 17:S11–S21
Levi M, Peters M, Buller HR (2005) Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review. Crit Care Med 33:883–890
Boffard KD, Riou B, Warren B, et al (2005) Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59:8–18
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Rossaint, R., Spahn, D.R. (2006). Trauma: Bleeding, Coagulopathy, and Blood Component Transfusion. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine, vol 2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-33396-7_24
Download citation
DOI: https://doi.org/10.1007/3-540-33396-7_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-30155-4
Online ISBN: 978-3-540-33396-8
eBook Packages: MedicineMedicine (R0)